We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
U-Haul Holding Co
UHAL
$14.6B
| $8.79M | 0.02% |
158,853
+117,740
| +286% | +$6.91M |
|
777
Sigma Lithium
SGML
$1.28B
| $8.79M | 0.02% |
218,057
+66,980
| +44% | +$2.55M |
|
778
Reinsurance Group of America
RGA
$16.1B
| $8.75M | 0.02% |
63,098
+60,598
| +2,424% | +$8.62M |
|
779
Tencent Music
TME
$15.6B
| $8.73M | 0.02% |
+1,182,425
| New | +$8.93M |
|
|
GOGL
780
DELISTED
Golden Ocean Group
GOGL
| $8.69M | 0.02% |
+1,150,714
| New | +$9.59M |
|
781
Sony
SONY
$138B
| $8.69M | 0.02% |
+482,445
| New | +$9.05M |
|
782
iShares US Medical Devices ETF
IHI
$3.37B
| $8.65M | 0.02% |
153,266
+146,402
| +2,133% | +$8.06M |
|
|
AMED
783
DELISTED
Amedisys
AMED
| $8.62M | 0.02% |
94,291
+2,994
| +3% | +$246K |
|
|
RETA
784
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $8.62M | 0.02% |
84,508
-330,446
| -80% | -$31.3M |
|
|
CBAY
785
DELISTED
Cymabay Therapeutics
CBAY
| $8.56M | 0.02% |
781,735
+538,554
| +221% | +$5.01M |
|
786
PUT
UnitedHealth
UNH
$370B
| $8.56M | 0.02% |
17,800
+7,400
| +71% | +$3.62M |
|
787
State Street SPDR S&P Insurance ETF
KIE
$688M
| $8.52M | 0.02% |
208,388
+106,208
| +104% | +$4.23M |
|
788
Sprout Social
SPT
$621M
| $8.49M | 0.02% |
183,964
+163,338
| +792% | +$7.77M |
|
789
Sherwin-Williams
SHW
$89.8B
| $8.48M | 0.02% |
31,934
-66,476
| -68% | -$15.7M |
|
790
Sanmina
SANM
$10.9B
| $8.47M | 0.02% |
140,524
+136,717
| +3,591% | +$7.49M |
|
|
EXAI
791
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $8.44M | 0.02% |
1,425,148
| – | – |
|
|
LUCK
792
Lucky Strike Entertainment
LUCK
$911M
| $8.43M | 0.02% |
724,259
-652,448
| -47% | -$8.7M |
|
793
EnerSys
ENS
$6.99B
| $8.42M | 0.02% |
+77,579
| New | +$7.08M |
|
|
TGI
794
DELISTED
Triumph Group
TGI
| $8.42M | 0.02% |
680,585
+653,233
| +2,388% | +$7.45M |
|
795
Newell Brands
NWL
$2.56B
| $8.4M | 0.02% |
+965,894
| New | +$9.61M |
|
|
ICNC.WS
796
CALL
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
| $8.39M | 0.02% |
787,857
-20,407
| -3% | -$2.78K |
|
797
GSK
GSK
$106B
| $8.38M | 0.02% |
235,094
-1,574,261
| -87% | -$56.5M |
|
798
G-III Apparel Group
GIII
$1.5B
| $8.35M | 0.02% |
433,353
+320,202
| +283% | +$5.51M |
|
799
World Kinect Corp
WKC
$1.86B
| $8.34M | 0.02% |
403,164
+189,087
| +88% | +$4.5M |
|
800
Cytokinetics
CYTK
$10.4B
| $8.33M | 0.02% |
255,392
-489,915
| -66% | -$18.1M |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.